Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-13-044981
Filing Date
2013-09-19
Accepted
2013-09-19 21:06:57
Documents
1
Period of Report
2013-09-17

Document Format Files

Seq Description Document Type Size
1 MAIN DOCUMENT DESCRIPTION c599061_4x0.html 4  
1 MAIN DOCUMENT DESCRIPTION c599061_4x0.xml 4 5934
  Complete submission text file 0001209191-13-044981.txt   7641
Mailing Address 8001 ARISTA PLACE SUITE 430 BROOMFIELD CO 80021
Business Address 8001 ARISTA PLACE SUITE 430 BROOMFIELD CO 80021 720-940-2200
ARCA biopharma, Inc. (Issuer) CIK: 0000907654 (see all company filings)

EIN.: 363855489 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address 40 WASHINGTON STREET SUITE 220 WELLESLEY HILLS MA 02481
Business Address
ZABRISKIE JOHN L (Reporting) CIK: 0001128329 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 000-22873 | Film No.: 131106588
SIC: 2834 Pharmaceutical Preparations